The intriguing biology of stem cells and their vast clinical potential is emerging rapidly for
gene therapy. Bone marrow stem cells, including the pluripotent haematopoietic stem cells …

The contributions of mesenchymal stem cells (MSCs) to tumour growth and stroma formation
are poorly understood. Tumour cells can transfer genetic information and modulate cell …

Magnetic nanoparticles (MNPs) represent a promising nanomaterial for the targeted therapy
and imaging of malignant brain tumors. Conjugation of peptides or antibodies to the surface …

The poor prognosis for patients with advanced malignancy relates partly to the inability to
reverse cancer metastasis. In this study we have investigated an integrated immunotherapy …

Background Although multimodality treatment can induce high rate of remission in many
subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with …

Clinical trials of gene therapy using a viral delivery system for glioma have been limited.
Recently, gene therapy using stem cells as the vehicles for delivery of therapeutic agents …

Background Previously, we validated capability of human adipose tissue‐derived
mesenchymal stem cells (AT‐MSC) to serve as cellular vehicles for gene‐directed enzyme …

Dielectrophoresis (DEP) is an electrokinetic technique with proven ability to discriminate and
selectively manipulate cells based on their phenotype and physiological state, without the …

Recent evidence suggests that mesenchymal stem cells (MSC) selectively home to tumors,
where they contribute to the formation of tumor-associated stroma. This effect can be …

For over 30 years, stem cells have been used in the replenishment of blood and immune
systems damaged by the cancer cells or during treatment of cancer by chemotherapy or …